skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Regarding the Crius/Vistra transaction (and a previous question on the topic). When I asked RBC Direct Investing about tendering my shares they stated:
"Currently there is no tender offers available for KWH.UN. If you are referring to the Vistra energy take over of Crius Energy, when this take over has been finalized it will happen automatically."
Read Answer Asked by Peter on April 05, 2019
Q: They announced a bought deal today for 10 million shares at $0.80 per share. Beyond the dilution of existing shareholders, what does this mean for the stock? How do purchasers of shares in bought deals typically treat those shares, ie do they dispose of them over time or do they typically establish a long term holding?
Read Answer Asked by Matthew on April 05, 2019
Q: I have a well diversified RRSP which has me set. However, I would like to make more that 1.6% interest in my non-registered account. Can you recommend 2 ETFs for my non-registered account to make some travel/leisure money over 1 year?
Read Answer Asked by Danny-boy on April 05, 2019
Q: I keep about 10% of RRSP for what I call " opportunity buy". I bought GOOG in December 2018 when it dropped to 987 and last week sold it to buy Biogen dropped 29% in one day due the the cancellation of phrase 3 R&D on amyloid based Alzheimer drugs. Now it up almost 9% in one week and GOOG is back to the exact price that I sold it.
What is your thought: Hold on to BIIB - more rrom to run or get back to GOOG?

Thank you!
Read Answer Asked by Nhung on April 05, 2019
Q: I would like your comments on the Brookfield group of companies. You have BEP.UN in your income account. How would you rank these. I am a retired 77 year old interested in a conservative dividend generating portfolio. Have have BEP.UN and BPY.UN in my portfolio.

Thank you.



Read Answer Asked by Donald on April 05, 2019
Q: I am finding your 'Portfolio Analytics' to be an outstanding service. The imbalances within my portfolios are abundantly clear.
I am overweight financials with
TD - 3.55%
JPM - 5.19%
BAC - 6.77%
GSY - 1.29%
CXI - 0.71%
All stocks show a decent profit except for CXI which is down 23%.
I have fairly high risk tolerance and I look for reasonable growth. I would appreciate your recommendations on how to reduce my financials by approximately 3%
Read Answer Asked by Ed on April 05, 2019
Q: Prometic is refilling an amendment to the BLA for plasminogen in H2 2019. If approved this orphan drug with fast track designation comes with a priority voucher possibly worth 100 million. Lazard has 2 deals to close in H2 as well which depend on approval. That said they need cash badly and announced an eminent debt restructuring. There at 20 cents today. What's your best guess on what happens to the float and share price after this. Do they have to give the company away at these to raise 100 million when possibly 200 million is coming their way this year.
Read Answer Asked by Steve on April 05, 2019
Q: Hi 5i,

can you help by suggesting a list of "quality" Canadian listed stocks which meet the following criteria:
1. good diversified global exposure
2. low or no dividend
3. decent liquidity
4. not too volatile
5. can be any market capitalization
Does BAM.A fit this criteria?
Hopefully you can suggest many more for me to look at.

thanks
Read Answer Asked by Ian on April 05, 2019
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!